These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 3514234

  • 1. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.
    De Villartay JP, Griscelli C, Fischer A.
    Eur J Immunol; 1986 Feb; 16(2):117-22. PubMed ID: 3514234
    [Abstract] [Full Text] [Related]

  • 2. Self-nonself discrimination and repertoire selection of human T cells differentiated in an HLA-semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency.
    Knobloch C, Goldmann SF, Friedrich W.
    Eur J Immunol; 1991 Oct; 21(10):2479-87. PubMed ID: 1833204
    [Abstract] [Full Text] [Related]

  • 3. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A, Dror Y, Benkerrou M, Colombe BW, Cowan MJ.
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [Abstract] [Full Text] [Related]

  • 4. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH.
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [Abstract] [Full Text] [Related]

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 6. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J, Gjertson D, Cecka M, Tonai R, Przepiorka D, Hunt L, Giralt S, Chan KW, Feig S, Territo M, Andersson B, van Besien K, Khouri I, Fischer H, Babbitt L, Ippolitti C, Schiller G, Lill M, Warkentin D, Neumann J, Petz L, Terasaki P, Champlin R.
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J.
    Verh K Acad Geneeskd Belg; 1998 Jun; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [Abstract] [Full Text] [Related]

  • 8. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
    Bacchetta R, Vandekerckhove BA, Touraine JL, Bigler M, Martino S, Gebuhrer L, de Vries JE, Spits H, Roncarolo MG.
    J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
    [Abstract] [Full Text] [Related]

  • 9. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
    Schiff SE, Buckley RH.
    J Immunol; 1987 Apr 01; 138(7):2088-94. PubMed ID: 2881966
    [Abstract] [Full Text] [Related]

  • 10. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May 01; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 11. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL, Volkman DJ, Buckley RH.
    J Immunol; 1989 Sep 01; 143(5):1575-9. PubMed ID: 2474604
    [Abstract] [Full Text] [Related]

  • 12. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F, Raffoux C, Griscelli C, Fischer A.
    J Immunol; 1987 Jan 15; 138(2):423-7. PubMed ID: 3540121
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep 15; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

  • 14. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM, Kessler FL, Verdonck LF, Stadhouders-Keet SA, van Lier RA, de Gast GC, Otten HG.
    Br J Haematol; 2000 Dec 15; 111(3):791-6. PubMed ID: 11122139
    [Abstract] [Full Text] [Related]

  • 15. A SCID patient reconstituted with HLA-incompatible fetal stem cells as a model for studying transplantation tolerance.
    Roncarolo MG, Bacchetta R, Bigler M, Touraine JL, de Vries JE, Spits H.
    Blood Cells; 1991 Dec 15; 17(2):391-402. PubMed ID: 1680508
    [Abstract] [Full Text] [Related]

  • 16. A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient.
    Tilkin AF, Bagot M, Kayibanda M, Vernant JP, Levy JP.
    J Immunol; 1986 Dec 15; 137(12):3772-6. PubMed ID: 3537123
    [Abstract] [Full Text] [Related]

  • 17. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens.
    Sondel PM, Hank JA, Trigg ME, Kohler PC, Finlay JL, Blank J, Meisner L, Borcherding W, Hong R, Steeves R.
    Exp Hematol; 1986 May 15; 14(4):278-86. PubMed ID: 3516715
    [Abstract] [Full Text] [Related]

  • 18. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA, Zantvoort E, Jacobs N, Bakker A, van Rood JJ, Goulmy E.
    Bone Marrow Transplant; 1990 Jun 15; 5(6):365-72. PubMed ID: 2142441
    [Abstract] [Full Text] [Related]

  • 19. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M, Yassai M, Tivol E, Krueger A, Gorski J, Drobyski WR.
    Biol Blood Marrow Transplant; 2003 Dec 15; 9(12):742-52. PubMed ID: 14677113
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.